|
A core laboratory approach to large-scale radiomics and machine-learning prediction of DLBCL outcomes after first-line treatment using results from the phase III GOYA study. |
|
|
Stock and Other Ownership Interests - Dixit |
Research Funding - AIRC; CRC; Fondazione IRCCS Istituto Tumori Milano; Roche |
Travel, Accommodations, Expenses - BTG; GE Healthcare; Philips Electronics; Siemens Healthineers; Sirtex Medical; TERUMO |
|
|
|
|
|
Employment - Precision Sensing |
|
|
|
Stock and Other Ownership Interests - Roche |
|
|
|
Stock and Other Ownership Interests - Roche |
|
|
|
Stock and Other Ownership Interests - Roche |
|
|
|
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - PET/X LLC |
Consulting or Advisory Role - Roche |
Research Funding - GE Healthcare |
Patents, Royalties, Other Intellectual Property - University of Washington |